Dumont & Blake Investment Advisors LLC Amgen Inc Transaction History

Dumont & Blake Investment Advisors LLC

$352 Million
Q3 2024

A detailed history of Dumont & Blake Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Dumont & Blake Investment Advisors LLC holds 8,897 shares of AMGN stock, worth $2.62 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

8,897

Previous 17,930 50.38%

Holding current value

$2.62 Million

Previous $5.6 Million 48.84%

% of portfolio

0.82%

Previous 0.84%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $2.79 Million - $3.05 Million	-9,033 Reduced 50.38%	8,897 $2.87 Million
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $2.36 Million - $2.87 Million	8,980 Added 100.34%	17,930 $5.6 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $5,377 - $6,491	20 Added 0.22%	8,950 $2.54 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $89,750 - $101,249	-351 Reduced 3.78%	8,930 $2.57 Million
Q3 2023 Oct 27, 2023	BUY	$218.65 - $271.46 $2,405 - $2,986	11 Added 0.12%	9,281 $2.49 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $37,925 - $44,846	-177 Reduced 1.87%	9,270 $2.06 Million
Q1 2023 Apr 14, 2023	SELL	$225.79 - $275.2 $31,610 - $38,528	-140 Reduced 1.46%	9,447 $2.28 Million
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $16,948 - $21,534	-74 Reduced 0.77%	9,587 $2.52 Million
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $173,956 - $196,191	-775 Reduced 7.43%	9,661 $2.18 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $137,041 - $152,503	-594 Reduced 5.39%	10,436 $2.54 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $10,524 - $11,643	48 Added 0.44%	11,030 $2.67 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $7,358 - $8,421	37 Added 0.34%	10,982 $2.47 Million
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $40,543 - $47,501	-191 Reduced 1.72%	10,945 $2.33 Million
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $15,416 - $17,103	66 Added 0.6%	11,136 $2.71 Million
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $16,643 - $19,395	-75 Reduced 0.67%	11,070 $2.75 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $112,950 - $134,503	-522 Reduced 4.47%	11,145 $2.56 Million
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $40,594 - $45,144	173 Added 1.51%	11,667 $2.97 Million
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $60,332 - $74,035	-305 Reduced 2.58%	11,494 $2.71 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $19,864 - $26,345	-109 Reduced 0.92%	11,799 $2.39 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $6,811 - $8,755	36 Added 0.3%	11,908 $2.87 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $296,857 - $355,697	-1,705 Reduced 12.56%	11,872 $2.3 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $83,183 - $97,509	499 Added 3.82%	13,577 $2.5 Million
Q1 2019 Apr 04, 2019	BUY	$180.87 - $203.88 $18,087 - $20,388	100 Added 0.77%	13,078 $2.49 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $23,013 - $26,864	-129 Reduced 0.98%	12,978 $2.53 Million
Q3 2018 Oct 19, 2018	BUY	$185.29 - $208.89 $44,469 - $50,133	240 Added 1.87%	13,107 $2.72 Million
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $24,907 - $27,976	150 Added 1.18%	12,867 $2.38 Million
Q1 2018 Apr 26, 2018	SELL	$169.43 - $198.0 $13,554 - $15,840	-80 Reduced 0.63%	12,717 $2.17 Million
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $6,751 - $7,543	-40 Reduced 0.31%	12,797 $2.23 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $2.15 Million - $2.45 Million	12,837	12,837 $2.39 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.

Account

Dumont & Blake Investment Advisors LLC Amgen Inc Transaction History